Oregon Cancer

News and information for cancer services throughout Oregon.

  • Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

    Read Article
  • VOICES of Black Women: A community study in cancer prevention and care

    VOICES of Black Women: A community study in cancer prevention and care

    A new study focused on stories will change health outcomes for Black women.

    Read Article
  • Leading the way: Providence researchers at AACR Annual Meeting

    Leading the way: Providence researchers at AACR Annual Meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

    A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

    Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.

    Read Article
  • Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

    Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

    Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.

    Read Article
  • Celebrating oncology social workers: Compassion, expertise and impact

    Celebrating oncology social workers: Compassion, expertise and impact

    We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.

    Read Article
  • 6 things everyone should know about oncology palliative care

    6 things everyone should know about oncology palliative care

    Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.

    Read Article
  • Clinical trial seeks better first-line therapy for follicular lymphoma

    Clinical trial seeks better first-line therapy for follicular lymphoma

    The study may redefine care for many people at the earliest stage of their treatment.

    Read Article
  • Where curiosity meets impact: Women in science at Providence Cancer Institute

    Where curiosity meets impact: Women in science at Providence Cancer Institute

    Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.

    Read Article
  • A new strategy for treating locally advanced cervical cancer

    A new strategy for treating locally advanced cervical cancer

    A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.

    Read Article
  • Personalizing lymphoma treatment: New study seeks better outcomes

    Personalizing lymphoma treatment: New study seeks better outcomes

    A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.

    Read Article
  • From patient to volunteer: Marge’s gift of gratitude

    From patient to volunteer: Marge’s gift of gratitude

    Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.

    Read Article
  • Reflecting on 2025, building toward 2026

    Reflecting on 2025, building toward 2026

    Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

    Read Article
  • Novel AI framework anticipated to unlock tumor secrets, lead to new treatments

    Novel AI framework anticipated to unlock tumor secrets, lead to new treatments

    Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research

    Read Article
  • Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection

    Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection

    Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

    Read Article
  • A precision oncology revolution is underway at Providence

    A precision oncology revolution is underway at Providence

    Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.

    Read Article
  • 2025 SITC Meeting: Three Providence researchers honored at 40th anniversary

    2025 SITC Meeting: Three Providence researchers honored at 40th anniversary

    Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

    Read Article
  • Transforming outcomes in AML and breast cancer: Three open trials at Providence

    Transforming outcomes in AML and breast cancer: Three open trials at Providence

    New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

    Read Article
  • Oregon cancer leaders unite to discuss research and policy

    Oregon cancer leaders unite to discuss research and policy

    Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

    Read Article
  • Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.

    Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.

    Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

    Read Article
  • loading
    Loading More...